Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | BTK | Q06187 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4971669 | 1.00 | EPHX1 (0.33) | EPHX1HTR2CSLC6A4BTKGAA | |
| SCHEMBL1424706 | 0.98 | EPHX1 (0.35) | EPHX1HTR2CSLC6A4GAATSHR | |
| SCHEMBL4753063 | 0.98 | EPHX1 (0.35) | EPHX1HTR2CSLC6A4GAATSHR | |
| SCHEMBL4971967 | 0.85 | ASGR1 (0.30) | — | |
| SCHEMBL4971964 | 0.85 | ASGR1 (0.30) | — | |
| SCHEMBL4969953 | 0.84 | GAA (0.34) | EPHX1BTKGAATSHRCTSS | |
| SCHEMBL4970498 | 0.84 | GAA (0.34) | EPHX1BTKGAATSHRCTSS | |
| SCHEMBL1607958 | 0.83 | EPHX1 (0.35) | EPHX1HTR2CSLC6A4BTKGAA | |
| SCHEMBL4972581 | 0.82 | GAA (0.36) | EPHX1BTKGAATSHRCTSS | |
| SCHEMBL4972576 | 0.82 | GAA (0.36) | EPHX1BTKGAATSHRCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3044226-A1 | ARYL ETHER-BASE KINASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2016-07-20 | — | — | EP | disclosed |
| WO-2015038112-A1 | ARYL ETHER-BASE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2015-03-19 | — | — | WO | disclosed |
| EP-2822555-A2 | INHIBITION OF ADAPTOR ASSOCIATED KINASE 1 FOR THE TREATMENT OF PAIN | Lexicon Pharmaceuticals, Inc. (US) | 2015-01-14 | — | — | EP | disclosed |
| EP-2822952-A1 | ARYL ETHER-BASE KINASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2015-01-14 | — | — | EP | disclosed |
| EP-2822559-A1 | IMIDAZO [1, 2 - B]PYRIDAZINE - BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND USES THEREOF | Lexicon Pharmaceuticals, Inc. (US) | 2015-01-14 | — | — | EP | disclosed |
| WO-2013134219-A1 | IMIDAZO [1, 2 - B] PYRIDAZINE - BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND USES THEREOF | LEXICON PHARMACEUTICALS, INC. (US) | 2013-09-12 | — | — | WO | disclosed |
| WO-2013134036-A1 | ARYL ETHER-BASE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2013-09-12 | — | — | WO | disclosed |
| WO-2013134336-A2 | INHIBITION OF ADAPTOR ASSOCIATED KINASE 1 FOR THE TREATMENT OF PAIN | LEXICON PHARMACEUTICALS, INC. (US) | 2013-09-12 | — | — | WO | disclosed |
| EP-1966139-A1 | ASPARTIC PROTEASE INHIBITORS | Vitae Pharmaceuticals, Inc. (US) | 2008-09-10 | — | — | EP | disclosed |
| WO-2007070201-A1 | ASPARTIC PROTEASE INHIBITORS | VITAE PHARMACEUTICALS, INC. (US) | 2007-06-21 | — | — | WO | disclosed |